Marker Therapeutics, Inc. (MRKR)

1.33 0.00 (0.00%) USD  |  NASDAQ  |  Sep 01, 16:00
1.33 0.00 (0.00%) After-Hours: 20:00
More

Marker Therapeutics Revenue Estimates for Current Fiscal Year

Revenue Estimates for Current Fiscal Year Chart

View Revenue Estimates for Current Fiscal Year for MRKR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Revenue Estimates for Current Fiscal Year Chart
Start Trial

Historical Revenue Estimates for Current Fiscal Year Data

View and export this data back to 2024. Start Trial.
Date Value
August 20, 2026 --
August 17, 2026 --
July 09, 2026 --
June 30, 2026 --
May 19, 2026 --
May 18, 2026 --
May 17, 2026 --
March 20, 2026 --
March 19, 2026 --
January 05, 2026 --
December 31, 2025 --
December 23, 2025 --
December 08, 2025 --
November 14, 2025 --
October 06, 2025 --
Date Value
August 26, 2025 --
August 15, 2025 --
June 17, 2025 --
May 20, 2025 --
May 16, 2025 --
May 09, 2025 --
March 31, 2025 --
March 05, 2025 --
February 10, 2025 --
December 31, 2024 --
November 15, 2024 --
October 21, 2024 --
August 16, 2024 --
June 13, 2024 --
April 30, 2024 --

Revenue Estimates for Current Fiscal Year Range, Past 5 Years

View Revenue Estimates for Current Fiscal Year Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue Estimates for Current Fiscal Year Benchmarks

View Revenue Estimates for Current Fiscal Year Benchmarks
Start Trial
Krystal Biotech, Inc. Upgrade
Ironwood Pharmaceuticals, Inc. Upgrade
SELLAS Life Sciences Group, Inc. Upgrade
Rezolute, Inc. Upgrade
ADMA Biologics, Inc. Upgrade

Revenue Estimates for Current Fiscal Year Related Metrics

Revenue Estimates for Current Quarter Upgrade
Revenue Estimates for Next Quarter Upgrade
Revenue Estimates for Next Fiscal Year Upgrade
EPS Estimates for Current Quarter Upgrade
EPS Estimates for Next Quarter Upgrade
EPS Estimates for Current Fiscal Year Upgrade
EPS Estimates for Next Fiscal Year Upgrade